{"text": "well worth listening to solange peters discussion of gild rcus arc 7 tigit data at the asco dec session"}
{"text": "gild gets its first us approval for twice yearly sunlenca the company told me the list price would be 39 000 per year for maintenance pricey but not quite as pricey as gsk s long acting cabenuva my quick take via"}
{"text": "rcus gild tbh domvanalimab pfs benefit looks somewhat believable their tigit is maybe not inert amp roche os data just got more interesting otherwise 1 zim etruma are probably zeroes 2 arc10 vs pembro is good luck"}
{"text": "never seen anything like this even during march 2020 bust institutions are selling or liquidating 93 100 of the qqq etf even including gild mdlz pep dam is about to break tsla spy amzn aapl"}
{"text": "gild"}
{"text": "gild gilead wins u s approval for twice yearly hiv med"}
